Comparative Pharmacology
Head-to-head clinical analysis: ACTICORT versus TRIACET.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ACTICORT versus TRIACET.
ACTICORT vs TRIACET
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Topical corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive actions. Suppresses cytokine production and inflammatory mediators via glucocorticoid receptor binding.
Triacetin is a triester of glycerol and acetic acid. Its exact mechanism of action is not fully understood, but it exhibits antifungal activity by disrupting fungal cell membrane integrity and inhibiting fungal growth.
5-60 mg orally once daily, or divided twice daily, depending on condition severity and response.
0.5-1 mg orally three times daily; maximum dose 4 mg/day.
None Documented
None Documented
1.5-2.5 hours; prolonged in hepatic impairment (up to 10 hours) and renal impairment (up to 6 hours)
Terminal elimination half-life is approximately 3.5–4 hours in adults with normal renal function; may be prolonged (up to 6–8 hours) in patients with hepatic impairment.
Renal (70% as unchanged drug and metabolites), biliary/fecal (30%)
Renal, unchanged drug: <1% of dose; metabolites: approximately 20% in urine, remainder in feces via biliary elimination.
Category C
Category C
Corticosteroid
Corticosteroid